Yes, it is possible to cure metastasy lung cancer or to achieve lasting remission, even if this remains a major medical challenge. We, Élise and Leo, wish to accompany you in this event with reliable and reassuring information. Here's what you need to remember:
- New targeted therapies and immunotherapy offer real opportunities for improvement
- Each case is unique and deserves personalized support
- Maintaining adapted physical activity significantly improves quality of life
- Smoking cessation, even after diagnosis, optimizes the chances of remission
This complex disease requires a comprehensive approach combining innovative treatments, psychological support and adapted hygiene.
Understanding metastasy lung cancer
Lung cancer is the leading cause of cancer death in France. We distinguish two very different situations: primitive cancers that are born directly in the lungs, and lung metastases from other organs (sein, colon, kidney).
Metastases develop mainly in bones, brain, liver and sometimes pancreas. This spread results from the circulation of cancer cells in the blood or lymphatic system.
We identify two main types of lung cancer. Small cell cancers account for 15 to 20% of cases and are characterized by their aggressiveness. Non-small cell cancers account for 80-85% of diagnoses and often respond better to modern therapies.
Causes and risk factors
Tobacco remains the leading cause, accounting for nearly 90% of lung cancers. All forms of smoking are concerned: cigarette, cigar, pipe, and even cannabis. Passive smoking also increases the risk, particularly among exposed children.
Age is an important factor: incidence increases gradually after 50 years, with a peak between 65 and 75 years. Occupational exposure to asbestos, heavy metals, hydrocarbons or radioactive substances greatly increases risks.
Air pollution is playing a growing role. Fine PM2.5 particles cause chronic inflammation that can trigger genetic mutations, even in non-smokers. Some genetic predispositions (EGFR, KRAS mutations) combined with these environmental exposures promote tumour development.
The symptoms to watch for
Early stages can be totally asymptomatic, making early diagnosis difficult. We encourage you to consult quickly if you have a persistent cough different from your habits, especially if it comes with bloody spitting.
Progressive shortness of breath, even during moderate efforts, is an alarm signal. Frequent or resistant respiratory infections with the usual treatments also deserve special attention.
Other signs may include chest pain, shoulder or arm, changes in voice, unexplained weight loss greater than 5% of body weight in a few months, intense and persistent fatigue.
Diagnostics and useful examinations
The assessment begins with a thorough medical examination including your personal and family history, lifestyle and professional exposures. Blood tests evaluate your general condition, liver and kidney function, as well as some tumour markers.
Medical imaging is the crucial step. Pulmonary X-ray allows for a first detection, but the chest scanner remains the reference examination to accurately visualize tumours. PET-scan identifies the metabolic activity of suspect cells throughout the organism.
Bronchoscopy allows direct exploration of the respiratory tract and sampling. Biopsy, carried out by different techniques depending on the location, definitively confirms the diagnosis and determines the precise histological type.
Possible treatments
Surgery remains the reference treatment when tumours are limited and technically accessible. It mainly concerns localized non-small cell cancers or some isolated metastases.
Chemotherapy works throughout the body to curb or reduce metastases. Modern protocols often combine several molecules to optimize efficiency while limiting side effects.
Radiotherapy specifically targets tumours to reduce or relieve symptoms (pain, cough, bleeding). Steretaxic radiation therapy delivers highly concentrated doses with millimetric accuracy.
Depending on the case, we can propose radiofrequency ablation to destroy small tumours, bronchial stents to keep the respiratory tract open, or thorcentesis to evacuate pleural effusions.
Innovative therapies (immunotherapy and targeted treatments)
Immunotherapy revolutionizes management by stimulating the immune system to specifically recognize and attack cancer cells. Control point inhibitors (anti-PD1, anti-PD-L1) have transformed the prognosis of many patients.
Targeted therapies affect specific genetic mutations present in certain tumours. Both tyrosine kinase inhibitors and anti-EGFR have remarkable results in 10-15% of patients with this mutation.
These personalized treatments require a prior molecular analysis of the tumour to identify therapeutic targets. Efficacy can be spectacular with a tolerance often better than conventional chemotherapy.
Can we cure for metastasis lung cancer?
Complete healing remains exceptional but prolonged remissions are possible, especially with innovative therapies. Five-year survival rates for non-small cell cancers now exceed 20% thanks to recent therapeutic advances.
Each situation is unique: your chances depend on the histological type, the number and location of metastases, your general condition and the treatments available. We observe patients in stage 4 who live several years with a preserved quality of life.
The therapeutic objective is to transform cancer into a controllable chronic disease, like diabetes or hypertension. This approach requires regular monitoring and therapeutic adjustments according to evolution.
Testimonials and stories of remission
We regularly encounter patients who have far exceeded initial predictions. Marie, 58 years old, diagnosed with bone and brain metastases, lives normally for 4 years thanks to immunotherapy.
Pierre, 62, former smoker with liver metastases, obtained a complete response under targeted anti-EGFR therapy. These testimonies illustrate the importance of hope and perseverance in the care path.
Smoking cessation, even after diagnosis, significantly improves the chances of response to treatments. Patients who maintain adequate physical activity better tolerate therapies and maintain a better quality of life.
Tips for better living with the disease
We strongly recommend maintaining regular physical activity, adapted to your abilities. Mild muscle building exercises, 20 to 30 minutes three times a week, improve treatment tolerance and reduce fatigue.
Nutrition management plays a crucial role. Prefer a high protein diet (1.2 to 1.5 g/kg body weight) to maintain muscle mass. Natural antioxidants (colored fruits, green vegetables) support your immune system.
Psychological support is essential. Don't hesitate to join speech groups or consult a psycho-oncologist. Meditation and relaxation techniques reduce anxiety and improve sleep quality.
The role of clinical trials and research
Clinical trials provide access to innovative treatments prior to marketing. They are often the best therapeutic option for patients in a deadlock situation.
Research is progressing rapidly: therapeutic vaccines, CAR-T cell therapies, new therapeutic combinations. We are witnessing an unprecedented acceleration in the development of new medicines.
Do not hesitate to discuss with your oncologist your eligibility for clinical trials. This participation also helps advance knowledge for future patients.
Prevention and importance of early detection
Primary prevention is based on complete cessation of tobacco. Nicotinic substitutes, electronic cigarette withdrawal and medical accompaniment multiply your chances of success by 3 to 4.
Reduce your environmental exposures: daily aeration of your home, avoid peaks of pollution, protect yourself from hazardous occupational substances. Low-dose scanner screening for large smokers over 50 years of age allows for early detection.
Hope, quality of life and future prospects
Therapeutic prospects have never been more promising. Artificial intelligence accelerates the discovery of new molecules, personalized medicine develops, combined therapies optimize results.
We encourage our patients to maintain their life plans. Many resume a suitable professional activity, travel, engage in leisure activities. Hope is not a luxury but a therapeutic necessity.
Your care path requires patience and determination. Surround yourself with a trusted medical team, maintain your social ties and never forget that every day counts. We are here to accompany you in this event with kindness and professionalism.
